Top compounds associated with response to HACD4


Feature Type Standardized
Nominal ANOVA
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.021 0.7
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.02 0.7
mRNA MI-2 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA Docetaxel gCSI pan-cancer AAC 0.022 0.7
mRNA VX-702 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA KIN001-260 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA bendamustine CTRPv2 pan-cancer AAC 0.016 0.7
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.021 0.7
Download CSV